share_log

奥赛康:关于子公司马来酸奈拉替尼片获得药品注册证书的公告

Osecon: Announcement on Subsidiary Nelatinib Maleate Tablets Obtaining a Drug Registration Certificate

SZSI ·  Oct 29, 2024 12:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more